Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|November 15, 2021
Superselective Transarterial Chemoembolization for Unresectable or "Ablation Unsuitable" Hepatocellular Carcinoma in the Caudate Lobe: A Real World, Single-Center Retrospective StudyLiangliang Yan, Yanqiao Ren, Kun Qian, et al.
International Immunopharmacology|March 5, 2024
Radiofrequency hyperthermia enhances the effect of OK-432 for Hepatocellular carcinoma by activating of TLR4-cGAS-STING pathwayBo Sun, Qingqing Zhang, Tao Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2021
Interventional real-time optical imaging guidance for complete tumor ablationXuefeng Kan, Feng Zhang, Guanhui Zhou, et al.
Journal of Oncology|March 31, 2022
A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor ThrombusTao Sun, Lei Chen, Xuefeng Kan, et al.
Cell Death & Disease|April 13, 2025
Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinomaBo Sun, Jiayun Liu, Xiaocui Liu, et al.
Immunotargets and Therapy|September 24, 2025
Anti-CD24 Antibody Plus Liposomal Doxorubicin for the Management of Residual Cancers After Incomplete Radiofrequency AblationJiayun Liu, Bo Sun, Jing Li, et al.
Journal of Neurointerventional Surgery|March 20, 2025
Clinical outcomes of carotid artery stenting with open- versus closed-cell stentsGuilin Zhang, Dongqiao Xiang, Haohao Lu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 25, 2023
Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinomaTao Sun, Bo Sun, Yanyan Cao, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 28, 2016
Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency AblationXuefeng Kan, Yanrong Zhang, Chuansheng Zheng, et al.
BMC Gastroenterology|April 21, 2021
Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative studyLiangliang Yan, Yanqiao Ren, Kun Qian, et al.
Pageof 7